Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
    3.
    发明授权
    Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant 有权
    使用吸入性气体一氧化氮作为粘膜溶解剂或祛痰剂

    公开(公告)号:US08518457B2

    公开(公告)日:2013-08-27

    申请号:US11595108

    申请日:2006-11-10

    IPC分类号: A61K33/00 A61M16/00 A61M16/10

    CPC分类号: A61K33/00 A61K9/007

    摘要: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.

    摘要翻译: 提供了通过施用气体吸入一氧化氮或一氧化氮释放化合物作为粘液溶解剂或祛痰剂来治疗哺乳动物中过量粘液积累的方法和装置。 气态一氧化氮的输送可以鼻或口服制成,优选地基本上与哺乳动物的吸入或基于哺乳动物呼吸循环的同步参数一致。 根据过量粘液积聚的严重程度,不同的治疗方案可用于输送气态一氧化氮。 用于治疗特征的参数可以包括含有一氧化氮的气体的流速,含有一氧化氮的气体的施用持续时间,要施用一氧化氮的气体的呼吸次数和输送到气道的治疗性NO的浓度。

    Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
    7.
    发明授权
    Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma 有权
    在体外电路中使用一氧化氮气体来治疗血浆

    公开(公告)号:US07531133B2

    公开(公告)日:2009-05-12

    申请号:US11445965

    申请日:2006-06-01

    IPC分类号: A61M1/00 A61M37/00 C02F1/44

    摘要: A method of reducing pathogens in blood by exposure to a nitric oxide containing gas in an extracorporeal circuitry is provided. The method includes: obtaining blood from a mammal or a blood source, separating the blood into plasma and blood cells, exposing the plasma to nitric oxide containing gas, combining the exposed plasma with the blood cells, reducing nitric oxide content in the recombined blood, and returning the blood to the mammal or blood source.

    摘要翻译: 提供了通过在体外电路中暴露于含有一氧化氮的气体来减少血液中的病原体的方法。 该方法包括:从哺乳动物或血液源获得血液,将血液分离成血浆和血细胞,将血浆暴露于含有一氧化氮的气体中,将暴露的血浆与血细胞结合,减少重组血液中的一氧化氮含量, 并将血液返回哺乳动物或血源。

    Models of Alzheimer's disease
    9.
    发明授权
    Models of Alzheimer's disease 失效
    阿尔茨海默病模型

    公开(公告)号:US5994084A

    公开(公告)日:1999-11-30

    申请号:US596100

    申请日:1996-08-23

    摘要: Transgenic cell and animal models for Alzheimer's disease are described. Cells of the animals and the cell models themselves comprise a recombinant DNA construct comprising a control sequence and, under the control of the control sequence, a DNA sequence encoding a kinase that is capable, directly or indirectly, of modulating the phosphorylation of the microtubule-forming protein tau. The transgenic cells and animals may be used for testing potential therapeutic agents for Alzheimer's disease.

    摘要翻译: PCT No.PCT / GB94 / 01669 Sec。 371日期:1996年8月23日 102(e)日期1996年8月23日PCT 1994年8月1日PCT公布。 公开号WO95 / 05466 日期1995年2月23日描述了阿尔茨海默病的转基因细胞和动物模型。 动物细胞和细胞模型本身包含重组DNA构建体,其包含对照序列,并且在对照序列的控制下,编码能够直接或间接调节微管 - 磷酸化磷酸化的激酶的DNA序列, 形成蛋白质tau蛋白。 转基因细胞和动物可用于测试阿尔茨海默病的潜在治疗剂。